Valuation: Aptahem AB

Chart: Aptahem AB

26/09	Aptahem enters letter of intent for collaboration with professor	FW
18/09	Aptahem trades today on Spotlight excluding unit rights in rights issue	FW
14/09	Aptahem carries out a rights issue, raising SEK 15.6m	FW
31/08	Aptahem steps up partnering work around Apta-1	FW
27/08	Aptahem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
27/08	Aptahem reports, as expected, unchanged results, CEO: working to move Apta-1 forward	FW
25/08	Aptahem, Jarlen Capital Sign Asset Outlicensing, Commercial Partnership Deal	MT
25/08	Aptahem signs partnership agreement with Jarlen Capital	FW
17/06	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
17/06	Aptahem Reports Improved Production of Apta-1	FW
29/05	Aptahem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
28/05	Aptahem reports narrowed operating loss	FW
11/05	Aptahem to focus on conditions mirroring sepsis pathology - newsletter	FW

19/09/25

25/08	Aptahem: Aptahem enters commercial partnership agreement with Jarlen Capital for outlicensing	PU
25/08	Aptahem enters commercial partnership agreement with Jarlen Capital for outlicensing	AQ
22/06	Aptahem: Newsletter June 2026	PU
22/06	Newsletter June 2026	AQ
17/06	Aptahem: Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	PU

Manager	Title	Age	Since
Luiza Jedlina CTO	Chief Tech/Sci/R&D Officer	-	01/03/2016
Knut Mikael Ingolf Lindstam CEO	Chief Executive Officer	60	01/01/2014
Ola Skanung DFI	Director of Finance/CFO	62	-

Director	Title	Age	Since
Knut Mikael Ingolf Lindstam BRD	Director/Board Member	60	01/01/2014
Johan Lindh BRD	Director/Board Member	-	-
Ulla Cristina Glad BRD	Director/Board Member	74	01/06/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APTAHEM AB	-2.78%	+8.02%	-71.07%	-98.40%	941K
WUXI APPTEC CO., LTD.	-0.37%	-3.67%	+57.21%	+87.75%	72.26B
ARGENX SE	-0.07%	-2.70%	+37.74%	+86.90%	60.24B
WUXI BIOLOGICS (CAYMAN) INC.	+3.84%	+5.32%	+40.03%	+21.47%	27.73B
INSMED INCORPORATED	-0.14%	-2.75%	-14.13%	+356.79%	25.73B
BIONTECH SE	+0.57%	+1.10%	+1.02%	-2.89%	24.75B
GENMAB A/S	+1.10%	+1.86%	+25.07%	-7.59%	20.74B
PHARMAESSENTIA CORPORATION	-1.70%	+0.43%	+150.24%	+323.16%	15.06B
EXELIXIS, INC.	+0.36%	+2.01%	+49.51%	+160.70%	14.41B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+4.13%	-3.35%	-4.40%	+518.54%	14.23B
Average	+0.49%	+1.16%	+27.12%	+144.64%	27.52B
Weighted average by Cap.	+0.53%	-1.08%	+38.57%	+129.69%

Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.

Employees

Sector

Date	Price	Change	Volume
28/09/26	SEK 0.3500	-2.78%	528,754
25/09/26	SEK 0.3600	+4.65%	205,741
24/09/26	SEK 0.3440	+9.21%	75,538
23/09/26	SEK 0.3150	+1.29%	230,657
22/09/26	SEK 0.3110	-4.01%	495,348